Olanzapine (Zyprexa) is approved to treat schizophrenia in adults and children ages 13 years and older, manic and mixed episodes related to bipolar I disorder in adults and children ages 13 years and ...

Nov. 25, 2003 — Olanzapine therapy did not demonstrate advantages over haloperidol in the treatment of schizophrenia, according to results of a double-blind, randomized, multicenter controlled trial, ...

The addition of olanzapine (Zyprexa) to standard antiemetic therapy among patients receiving highly emetogenic chemotherapy provides better nausea and vomiting relief across subgroups at high risk for ...

Lybalvi (olanzapine/samidorphan) can cause mild or serious side effects. These side effects may be temporary, lasting a few days to weeks. More common mild side ...

Atypical antipsychotics are at least equivalent to typical antipsychotics in treating the positive symptoms of schizophrenia, and seem to be more effective in treating negative, cognitive, and mood ...

L ow-dose semaglutide (Ozempic, Wegovy) improved glycemic control and weight outcomes in a randomized trial of adults whose ...

Second-generation (atypical) antipsychotic drugs are widely used to treat psychosis, aggression, and agitation in patients with Alzheimer's disease, but their benefits are uncertain and concerns about ...

Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient This investigator-initiated, ...

Olanzapine represents a second-generation atypical antipsychotic agent that is currently approved for the treatment of psychotic disorders, schizophrenia, schizoaffective disorders, mania, and other ...

Stage III Non–Small-Cell Lung Cancer Treated With Concurrent Chemoradiation Followed or Not by Consolidation Chemotherapy: A Survival Analysis From a Brazilian Multicentric Cohort Chemotherapy-induced ...